0001870913-23-000005.txt : 20230830 0001870913-23-000005.hdr.sgml : 20230830 20230830162901 ACCESSION NUMBER: 0001870913-23-000005 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230828 FILED AS OF DATE: 20230830 DATE AS OF CHANGE: 20230830 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shanmugam Muthusamy CENTRAL INDEX KEY: 0001870913 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31812 FILM NUMBER: 231225586 MAIL ADDRESS: STREET 1: C/O ANI PHARMACEUTICALS, INC. STREET 2: 210 MAIN STREET WEST CITY: BAUDETTE STATE: MN ZIP: 56623 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ANI PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001023024 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 582301143 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 210 MAIN STREET WEST CITY: BAUDETTE STATE: MN ZIP: 56623 BUSINESS PHONE: 2186343500 MAIL ADDRESS: STREET 1: 210 MAIN STREET WEST CITY: BAUDETTE STATE: MN ZIP: 56623 FORMER COMPANY: FORMER CONFORMED NAME: BIOSANTE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19991228 FORMER COMPANY: FORMER CONFORMED NAME: BEN ABRAHAM TECHNOLOGIES INC DATE OF NAME CHANGE: 19991027 4 1 wk-form4_1693427333.xml FORM 4 X0508 4 2023-08-28 0 0001023024 ANI PHARMACEUTICALS INC ANIP 0001870913 Shanmugam Muthusamy C/O ANI PHARMACEUTICALS, INC. 210 MAIN STREET WEST BAUDETTE MN 56623 1 1 0 0 HEAD OF R&D, COO-NOVITIUM OPS 0 Common Stock 47407 D Common Stock 2023-08-28 4 S 0 25000 63.06 D 1157620 I Held by Esjay LLC Common Stock 2023-08-29 4 S 0 25000 63.37 D 1132620 I Held by Esjay LLC Common Stock 5000 I Held by SS Pharma LLC Reflects the weighted average price of sales on August 28, 2023. The shares were sold in multiple transactions at prices ranging from $62.57 to $64.64, inclusive. The reporting person holds voting and dispositive power over the shares held by Esjay LLC. Reflects the weighted average price of sales on August 29, 2023. The shares were sold in multiple transactions at prices ranging from $62.4877 to $63.92, inclusive. The Reporting Person holds voting and dispositive power over the shares held by SS Pharma LLC. /s/ Muthusamy Shanmugam, by attorney-in-fact Meredith W. Cook 2023-08-30